
    
      The study will focus on the number of patients moving to persistent Atrial Fibrillation as a
      function of cumulative %Vp (< or >40%), in a general dual-chamber pacemaker population
      through a 2 year follow-up (n=2188).

      The same endpoint will be analyzed in sub populations (Sinus Node Disease and AVB) at 4 years
      follow up (n=4290).
    
  